MOR — Morphosys AG Share News
0.000.00%
Last trade - 00:00- €2.53bn
- €2.16bn
- €238.28m
Brief: Morphosys Says Merger Squeeze-Out Cash Compensation Determined At Eur 68.00
Brief: Morphosys And Novartis Sign Delisting Agreement
Brief: Novartis BidCo Germany plans merger squeeze-out of Morphosys minority shareholders
Brief: Morphosys: Pichota and Lukas Gilgen replacing CEO And CFO
Brief: Novartis Meets All Tender Offer Conditions To Acquire Morphosys
Novartis to buy radiology specialist Mariana Oncology for $1 billion (updated)
Incyte misses quarterly profit on weak sales of lead drug
Deals of the day-Mergers and acquisitions
Brief: Morphosys AG Says 2024 Financial Guidance Published On January 30, 2024, Cannot Be Maintained And Therefore Was Revoked
Brief: MorphoSys Q1 Revenue EUR 27.5 Million
Deals of the day-Mergers and acquisitions
Morphosys says takeover by Novartis on course after report of drug safety concern (updated)
Deals of the day-Mergers and acquisitions
Morphosys says Novartis takeover progressing as planned for H1 2024
Brief: Morphosys To Present New Phase 3 Manifest-2 Data On Pelabresib In Myelofibrosis
Brief: MorphoSys’ Management Board, Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
Deals of the day-Mergers and acquisitions
Brief: Morphosys' Management And Supervisory Board Recommend Shareholders Accept Takeover Offer By Novartis
Novartis begins tender offer for MorphoSys (updated)